These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23979368)

  • 1. Time to recommend heparin and low-molecular-weight heparins in thromboprophylaxis in medical-surgical critically ill patients.
    Volpi N
    Crit Care Med; 2013 Sep; 41(9):2224-6. PubMed ID: 23979368
    [No Abstract]   [Full Text] [Related]  

  • 2. The landscape of thromboprophylaxis utilization in critically ill children: sparse and variable.
    Gist KM; Chima RS
    Crit Care Med; 2014 May; 42(5):1317-8. PubMed ID: 24736356
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.
    Alhazzani W; Lim W; Jaeschke RZ; Murad MH; Cade J; Cook DJ
    Crit Care Med; 2013 Sep; 41(9):2088-98. PubMed ID: 23782973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multinational study of thromboprophylaxis practice in critically ill children.
    Faustino EV; Hanson S; Spinella PC; Tucci M; O'Brien SH; Nunez AR; Yung M; Truemper E; Qin L; Li S; Marohn K; Randolph AG;
    Crit Care Med; 2014 May; 42(5):1232-40. PubMed ID: 24351371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboprophylaxis in immobilized medical patients.
    Vaitkus PT
    Eur J Med Res; 2004 Mar; 9(3):131-4. PubMed ID: 15096323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials.
    Park J; Lee JM; Lee JS; Cho YJ
    J Korean Med Sci; 2016 Nov; 31(11):1828-1837. PubMed ID: 27709864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
    Valiukiene L; Naudziūnas A; Unikauskas A
    Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of low-molecular-weight heparins in treating thrombosis.
    Lee AY
    J Support Oncol; 2006 Mar; 4(3):123-4. PubMed ID: 16553137
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-molecular-weight heparins: an overview for the podiatric physician.
    Smith RG
    J Am Podiatr Med Assoc; 2005; 95(4):383-9. PubMed ID: 16037555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism.
    Prandoni P
    J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of neuraxial anesthesia in patients receiving perioperative low-molecular-weight heparin for thromboprophylaxis.
    Llau JV
    Chest; 1999 Dec; 116(6):1843-4. PubMed ID: 10593829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of low molecular weight heparins in thromboembolic disease].
    Zuazu-Jausoro I; Lozano ML; Vicente V
    Rev Clin Esp; 2000 Aug; 200(8):447-8. PubMed ID: 11076184
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low-molecular weight heparins in pregnancy].
    Aguilera C; Vallano A
    Med Clin (Barc); 2002 May; 118(16):634-5. PubMed ID: 12028918
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboprophylaxis in arthroscopic surgery.
    Anand A
    Arthroscopy; 2014 Jul; 30(7):780. PubMed ID: 24951355
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients.
    Cook DJ; Crowther MA
    Crit Care Med; 2010 Feb; 38(2 Suppl):S76-82. PubMed ID: 20083918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency.
    Douketis JD; Rabbat C; Crowther MA;
    J Crit Care; 2005 Dec; 20(4):324-9. PubMed ID: 16310603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is low-molecular-weight heparin useful for venovenous hemofiltration in the intensive care unit?
    Spiegel DM; Anderson RJ
    Crit Care Med; 1999 Oct; 27(10):2316-7. PubMed ID: 10548241
    [No Abstract]   [Full Text] [Related]  

  • 18. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
    Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
    J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism.
    Ornstein DL; Hong-Dice YG; Papini JR
    Mil Med; 2001 Jul; 166(7):593-601. PubMed ID: 11469031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.